EUVIMEDEUVIMED entdecken
Crossref

A Real-world Study of Everolimus Plus Aromatase Inhibitor in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer

Gerasimos Ardavanis-Loukeris, Stefania Kokkali, Konstantina Perdikari, Eleni Karatrasoglou, Sofia Talagani, Alexandros Tzovaras, Alexandros Ardavanis

Anticancer Research · 2024

DOI: 10.21873/anticanres.16953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Gerasimos Ardavanis-Loukeris und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1 Medical Oncology Clinic, Saint-Savvas Anticancer Hospital, Athens, Greece. Hauptthemen laut MEDLINE: Everolimus, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EverolimusBreast NeoplasmsHumansFemaleErb-b2 Receptor Tyrosine KinasesAromatase InhibitorsRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsAndrostadienes

Stichwörter der Autor:innen

Metastatic breast cancereverolimus. real-life datahormone receptor-positive

Substanzen

EverolimusErb-b2 Receptor Tyrosine KinasesAromatase InhibitorsAndrostadienes

Autor:innen und Institutionen

  • 1 Medical Oncology Clinic, Saint-Savvas Anticancer Hospital, Athens, Greece.
  • 1 Medical Oncology Clinic, Saint-Savvas Anticancer Hospital, Athens, Greece; stefkokka@med.uoa.gr.
  • Oncology Unit, 2 Department of Medicine, National and Kapodistrian University of Athens, Medical School, Hippocratio General Hospital of Athens, Athens, Greece.

Zitieren

APA

Ardavanis-Loukeris, G., Kokkali, S., Perdikari, K., Karatrasoglou, E., Talagani, S., Tzovaras, A., & Ardavanis, A. (2024). A Real-world Study of Everolimus Plus Aromatase Inhibitor in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.16953

Vancouver

Ardavanis-Loukeris G, Kokkali S, Perdikari K, Karatrasoglou E, Talagani S, Tzovaras A, et al. A Real-world Study of Everolimus Plus Aromatase Inhibitor in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.16953

BibTeX
@article{ArdavanisLoukeris2024,
  author = {Ardavanis-Loukeris, Gerasimos and Kokkali, Stefania and Perdikari, Konstantina and Karatrasoglou, Eleni and Talagani, Sofia and Tzovaras, Alexandros and Ardavanis, Alexandros},
  title = {A Real-world Study of Everolimus Plus Aromatase Inhibitor in Hormone Receptor-positive, HER2-negative Advanced Breast Cancer},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.16953}
}
Kostenlos starten →